AptarGroup saw the highest growth of 1.44% in patent filings in May and 1.12% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.72% and grants by 1.12%. GlobalData’s DataBook provides a comprehensive analysis of AptarGroup’s patent filings and grants. Buy the databook here.
AptarGroup has been focused on protecting inventions in United States(US) with 33 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 32% filings and 23% grants. The United States(US), World Intellectual Property Organization(WIPO), China(CN), and France(FR) patent Office are among the top ten patent offices where AptarGroup is filings its patents. Among the top granted patent authorities, AptarGroup has 23% of its grants in United States(US), 16% in European Patent Office(EPO) and 12% in France(FR).
IPI Legacy Liquidation could be the strongest competitor for AptarGroup
Patents related to industrial automation and healthtech lead AptarGroup's portfolio
AptarGroup has the highest number of patents in industrial automation followed by, healthtech and remote patient monitoring. For industrial automation, nearly 15% of patents were filed and 47% of patents were granted in Q2 2024.
Packaging related patents lead AptarGroup portfolio followed by other remote patient monitoring, and disinfectants and sanitizers
AptarGroup has highest number of patents in packaging followed by other remote patient monitoring, disinfectants and sanitizers, drug delivery devices, and petrochemicals. For packaging, nearly 36% of patents were filed and 63% of patents were granted in Q2 2024.
For comprehensive analysis of AptarGroup's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.